<DOC>
	<DOCNO>NCT01775020</DOCNO>
	<brief_summary>Pilot data patient data pig study indicate arginine-NO metabolism impaired sepsis change splanchnic metabolism function , reduce survival low nitrate level . Prolonged intravenous supplementation L-arginine prove effective pig increase NO production , restore gut function , inhibit increase pulmonary arterial pressure , without deleterious systemic side effect . Prolonged intravenous L-arginine supplementation could therefore useful septic ICU patient .</brief_summary>
	<brief_title>Dose-response Study Arginine Supplementation Severe Sepsis</brief_title>
	<detailed_description />
	<mesh_term>Sepsis</mesh_term>
	<mesh_term>Toxemia</mesh_term>
	<mesh_term>Shock , Septic</mesh_term>
	<criteria>Written inform consent close relative Age &gt; 18 year Patient meet general criterion severe sepsis septic shock , diagnose less 48 h prior study inclusion ( see appendix A ; Dutch ) . Patient must relatively hemodynamically stable , define stable blood pressure ( variation mean arterial pressure &lt; 15 mm Hg ) 2 h without necessity increase vasopressor dose , inotropic support rate fluid administration . Systemic pulmonary arterial catheter place continuous pressure monitoring . Patients clinician prepared provide full life support duration study , include life expectance &gt; 24 h. Shock due cause sepsis ( e.g . drug reaction drug overdose , pulmonary embolus , burn injury etc . ) Corticosteroid use ( prolonged intake &gt; 1mg/kg daily intake &gt; 70 mg/day 7 consecutive day within 1 month precede study ) Liver cirrhosis Chronic pancreatitis Diabetes mellitus type I Metastases , haematological malignancy chemotherapy Patients dialysis ( CVVH )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2013</verification_date>
</DOC>